Tag archive for ‘BIONDVAX PHARMACEUTICALS LTD’
Jewish Business News On Monday, August 3rd, 2015

Independent Results: BiondVax’s Universal Flu Vaccine Administered in a Trial 3 years ago Improves Immunogenicity against Current Flu Vaccine

  BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) received the statistical analysis of results from a study which demonstrates that BiondVax’s universal flu vaccine (M-001), administered More...

Jewish Business News On Wednesday, June 17th, 2015

BiondVax Announces FDA Acceptance of IND Application for its Investigational Universal Flu Vaccine

– – Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, announced that its Investigational New Drug Application (IND) for its Multimeric-001 vaccine (M-001), More...

Wordpress site Developed by Fixing WordPress Problems